Showing results (331-340 of 427) with videos related to

Sort By:
Pageof 43
Cancers|June 4, 2020
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal AdenocarcinomaRocio I R Macias, Luis Muñoz-Bellvís, Anabel Sánchez-Martín, et al.
Cancers|December 16, 2020
Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and FibrosisAlex Claveria-Cabello, Leticia Colyn, Iker Uriarte, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2024
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3Maitane Asensio, Oscar Briz, Elisa Herraez, et al.
Scientific Reports|May 12, 2023
Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytesBarbara Oliviero, Michele Dei Cas, Aida Zulueta, et al.
Hepatology Communications|October 21, 2025
The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: A systematic reviewChiara Becchetti, Elton Dajti, Grace L Su, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2016
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitisSerge J Zweers, Alexey Shiryaev, Mina Komuta, et al.
Hepatology (Baltimore, Md.)|May 7, 2021
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.
Gut|December 28, 2020
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver diseaseMarta B Afonso, Pedro M Rodrigues, Miguel Mateus-Pinheiro, et al.
Hepatology (Baltimore, Md.)|April 12, 2019
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene TherapyElisa Lozano, Rocio I R Macias, Maria J Monte, et al.
Gut|May 17, 2022
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directionsRocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, et al.
Pageof 43